Transcription Factor Nrf2 Regulates Inflammation by Mediating the Effect of 15-Deoxy-Δ12,14-Prostaglandin J2

Molecular and Cellular Biology

Volumn 24, Issue 1, 2004, Pages 36-45

  Itoh, Ken ^a   Mochizuki, Mie ^a   Ishii, Yukio ^a   Ishii, Tetsuro ^a   Shibata, Takahiro ^b   Kawamoto, Yoshiyuki ^b   Kelly, Vincent ^a   Sekizawa, Kiyohisa ^a   Uchida, Koji ^a   Yamamoto, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ANTIOXIDANT; CARRAGEENAN; CELL SURFACE RECEPTOR; CYCLOOXYGENASE 2 INHIBITOR; HEME OXYGENASE 1; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PEROXIREDOXIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROTECTION; DETOXIFICATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC REGULATION; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PLEURISY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ANIMALS; CYCLOOXYGENASE 2; DNA-BINDING PROTEINS; HEPATOCYTES; INFLAMMATION; ISOENZYMES; MACROPHAGES; MICE; NF-E2-RELATED FACTOR 2; PERITONEUM; PLEURISY; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRANS-ACTIVATORS;

ANIMALIA;

EID: 10744230015     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.1.36-45.2004     Document Type: Article

References (46)

1. Aoki, Y., H. Sato, N. Nishimura, S. Takahashi, K. Itoh, and M. Yamamoto. 2001. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173:154-160.
2. Braun, S., C. Hanselmann, M. G. Gassmann, U. auf dem Keller, C. Born-Berclaz, K. Chan, Y. W. Kan, and S. Werner. 2002. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22:5492-5505.
3. 2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit. J. Biol. Chem. 276:35530-35536.
4. Chan, K., and Y. W. Kan. 1999. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA 96:12731-12736.
5. Chan, K., R. Lu, J. C. Chang, and Y. W. Kan. 1996. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. USA 93:13943-13948.
6. Chen, X. L., S. E. Varner, A. S. Rao, J. Y. Grey, S. Thomas, C. K. Cook, M. A. Wasserman, R. M. Medford, A. K. Jaiswal, and C. Kunsch. 2003. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J. Biol. Chem. 278:703-711.
7. Cho, H. Y., A. E. Jedlicka, S. P. Reddy, T. W. Kensler, M. Yamamoto, L. Y. Zhang, and S. R. Kleeberger. 2002. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell. Mol. Biol. 26:175-182.
8. 2 attenuates the development of acute and chronic inflammation. Mol. Pharmacol. 61:997-1007.
9. Dinkova-Kostova, A. T., W. D. Holtzclaw, R. N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99:11908-11913.
10. Di Rosa, M., J. P. Giroud, and D. A. Willoughby. 1971. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol. 104:15-29.
11. Enomoto, A., K. Itoh, E. Nagayoshi, J. Haruta, T. Kimura, T. O'Connor, T. Harada, and M. Yamamoto. 2001. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59:169-177.
12. Fukushima, M. 1992. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot. Essential Fatty Acids 47:1-12.
13. Gilroy, D. W., P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and D. A. Willoughby. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:698-701.
14. 2 is mediated by the stress response elements and transcription factor Nrf2. Antioxid. Redox Signal. 4:249-257.
15. Ishii, T., K. Itoh, and M. Yamamoto. 2002. Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements. Methods Enzymol. 348:182-190.
16. Ishii, T., K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275:16023-16029.
17. Ishii, T., M. Yamada, H. Sato, M. Matsue, S. Taketani, K. Nakayama, Y. Sugita, and S. Bannai. 1993. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268:18633-18636.
18. Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313-322.
19. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J. D. Engel, and M. Yamamoto. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76-86.
20. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, T. O'Connor, and M. Yamamoto. 2003. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8:379-381.
21. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
22. Jung, H., T. Kim, H. Z. Chae, K. T. Kim, and H. Ha. 2001. Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction. J. Biol. Chem. 276:15504-15510.
23. Kang, S. W., H. Z. Chae, M. S. Seo, K. Kim, I. C. Baines, and S. G. Rhee. 1998. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α. J. Biol. Chem. 273:6297-6302.
24. Kataoka, K., H. Handa, and M. Nishizawa. 2001. Induction of cellular anti-oxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds. J. Biol. Chem. 276:34074-34081.
25. 2. J. Biol. Chem. 278:19325-19330.
26. Metz, C. N., and R. Bucala. 1997. Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv. Immunol. 66:197-223.
27. 2 in nuclei. J. Pharmacol. Exp. Ther. 242:306-311.
28. Nathan, C. 2002. Points of control in inflammation. Nature 420:846-852.
29. 2. J. Lipid Mediat. Cell Signal. 12:443-448.
30. Otterbein, L. E., F. H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, R. J. Davis, R. A. Flavell, and A. M. Choi. 2000. Carbon monoxide has antiinflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:422-428.
31. Prestera, T., Y. Zhang, S. R. Spencer, C. A. Wilczak, and P. Talalay. 1993. The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enzyme Regul. 33:281-296.
32. Primiano, T., T. R. Sutter, and T. W. Kensler. 1997. Antioxidant-inducible genes. Adv. Pharmacol. 38:293-328.
33. Ramos-Gomez, M., M. K. Kwak, P. M. Dolan, K. Itoh, M. Yamamoto, P. Talalay, and T. W. Kensler. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98:3410-3415.
34. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82.
35. Roger, T., J. David, M. P. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920-924.
36. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403:103-108.
37. Seibert, K., Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson. 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 91:12013-12017.
38. 2 metabolite generated during inflammatory processes. J. Biol. Chem. 277:10459-10466.
39. Talalay, P., M. J. De Long, and H. J. Prochaska. 1988. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA 85:8261-8265.
40. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:232-235.
41. Venugopal, R., and A. K. Jaiswal. 1996. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93:14960-14965.
42. Warner, T. D., F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell, and J. R. Vane. 1999. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA 96:7563-7568.
43. Willis, D., A. R. Moore, R. Frederick, and D. A. Willoughby. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:87-90.
44. Willoughby, D. A., A. R. Moore, and P. R. Colville-Nash. 2000. Cyclopentenone prostaglandins - new allies in the war on inflammation. Nat. Med. 6:137-138.
45. Willoughby, D. A., A. R. Moore, P. R. Colville-Nash, and D. Gilroy. 2000. Resolution of inflammation. Int. J. Immunopharmacol. 22:1131-1135.
46. Yoh, K., K. Itoh, A. Enomoto, A. Hirayama, N. Yamaguchi, M. Kobayashi, N. Morito, A. Koyama, M. Yamamoto, and S. Takahashi. 2001. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 60:1343-1353.